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The success of pancreatic islet transplantation is limited by delayed engraftment and suboptimal function in 
the longer term. Endothelial progenitor cells (EPCs) represent a potential cellular therapy that may improve the 
engraftment of transplanted pancreatic islets. In addition, EPCs may directly affect the function of pancreatic 
b-cells. The objective of this study was to examine the ability of EPCs to enhance pancreatic islet transplanta-
tion in a murine syngeneic marginal mass transplant model and to examine the mechanisms through which this 
occurs. We found that cotransplanted EPCs improved the cure rate and initial glycemic control of transplanted 
islets. Gene expression data indicate that EPCs, or their soluble products, modulate the expression of the b-cell 
surface molecule connexin 36 and affect glucose-stimulated insulin release in vitro. In conclusion, EPCs are a 
promising candidate for improving outcomes in islet transplantation, and their mechanisms of action warrant 
further study.
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may occur through the provision of humoral factors, pro-
duction of basement membrane components, or via cell 
contact-dependent mechanisms.
Pancreatic islet transplantation is a promising therapy 
for the treatment of type 1 diabetes (25), but the majority of 
b-cells die in the early postoperative period (13). Starting 
with the organ procurement stage, through islet isolation, 
transport and culture, and posttransplantation, islets face 
a myriad of cell stresses including hypoxia and immune-
mediated damage (16,19,41). Posttransplantation, islet 
revascularization can take up to 1 month, and the ulti-
mate vascular density of the islet is often compromised. 
The provision of exogenous endothelial cells, or their 
precursors, at the time of transplantation is one strategy 
to improve islet revascularization and/or enhance b-cell 
function.
Endothelial progenitor cells (EPCs) are a circulating 
bone marrow-derived cell population first described by 
INTRODUCTION
The pancreatic islet is a complex, multicellular struc-
ture comprising multiple endocrine and nonendocrine cell 
types. In the native pancreas, islets are densely vascularized 
with specialized, fenestrated endothelium (2) and receive 
10% of pancreatic blood flow despite only making up 
1–2% of tissue mass (20). The vascular endothelium is cru-
cial for pancreatic development (6,24), and the importance 
of vascular endothelial cells for the survival and proper 
function of mature insulin-producing b-cells is beginning 
to become apparent (15,21,24,32,42). The impact of the 
intraislet endothelium is likely to be twofold. Firstly, as a 
conduit for blood supply, intraislet vasculature is crucial for 
the delivery of oxygen, sensing of blood glucose, dissemi-
nation of insulin, and removal of waste products. Secondly, 
within the islet, endothelial cells are in intimate contact 
with b-cells and directly enhance insulin transcription and 
secretion and stimulate b-cell proliferation (21,42). This 
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Asahara and colleagues (1). EPCs are able to home to 
sites of tissue damage or ischemia and can participate 
in wound healing, postnatal vasculogenesis, and reen-
dothelialization of blood vessels (18,35). While EPCs 
have the capacity to integrate into newly growing vessels, 
probably more important is their provision of humoral 
factors at the tissue damage site, which may recruit acces-
sory cells, support vessel remodeling, and elicit prosur-
vival responses.
This study examines the potential of EPCs to enhance 
the engraftment of transplanted pancreatic islets and 
investigates in vitro the mechanisms through which EPCs, 
or their secreted factors, modify islet cell gene expression 
and function.
MATERIALS AND METHODS
Antibodies and Reagents
Recombinant mouse tumor necrosis factor-a (TNF-a) 
was obtained from R&D Systems (Minneapolis, MN, 
USA). The following antibodies were used for experi-
ments: anti-mouse E-selectin antibody (clone UZ6; 
Abcam, Cambridge, UK; used at 10 µg/µl), immunoglob-
ulin G1b (IgG1b) isotype control (Abcam; used at 10 µg/
µl), anti-rat Alexa488 (Life Technologies, Mulgrave, 
Australia; used at 10 µg/µl), mouse fragment, crystalliz-
able region (Fc) block (BD Biosciences, San Jose, CA, 
USA; used at 5 µg/µl), phycoerythrin (PE)-labeled anti-
mouse cluster of differentiation 31 (CD31; Clone MEC 
13.3; BD Biosciences; used at 1:50), PE-labeled isotype 
control (BD Biosciences; used at 10 µg/µl), guinea pig 
anti-insulin (Abcam; used at 1:3,200), rabbit antifluo-
rescein (Life Technologies; used at 10 µg/µl), biotiny-
lated donkey anti-guinea pig (Abacus, East Brisbane, 
Australia; used at 1:100), and goat anti-rabbit Alexa647 
(Life Technologies; used at 10 µg/µl). Fluorescein-labeled 
tomato lectin was obtained from Vector Laboratories 
(Burlingame, CA, USA). Mefloquine was obtained from 
Sigma (St. Louis, MO, USA) and streptavidin- labeled 
cyanine 3 (Cy3) from Jackson Laboratories (West Grove, 
PA, USA; used at 1:100).
Endothelial Progenitor Cell Isolation and Culture
EPCs were derived from male C57B6 mice (Laboratory 
Animal Services, The University of Adelaide, Adelaide, 
Australia) as previously described (4,14). Bone marrow 
cells were obtained by flushing femurs and tibiae of 6- to 
12-week-old mice using M199 medium (Sigma #M0393). 
Cells were cultured on fibronectin (50 µl/ml; Roche, 
#10838039001; Basel, Switzerland) in 20% fetal calf 
serum (Gibco/Invitrogen, Carlsbad, CA, USA). Medium 
was supplemented with endothelial cell growth supple-
ment and heparin (both at 15 µg/ml; BD Biosciences, 
#356006; a tissue extract containing multiple growth 
factors including fibroblast growth factor, VEGF, and 
endothelial cell growth factors a and b), and heparin 
(BD Biosciences) (both at 15 µg/ml). Cells were har-
vested with 0.1% trypsin-ethylenediaminetetraacetic acid 
(EDTA) 2–3 min at 37°C (Sigma Aldrich, St. Louis, MO, 
USA) within 7 days of initial seeding. EPC-conditioned 
media was obtained from 90% confluent day 7 EPC cul-
tures, centrifuged (800 × g/5 min), sterile filtered (0.4 µm), 
and used immediately. In some experiments, EPCs were 
labeled with carboxyfluorescein diacetate succinimi-
dyl ester (CFDA; 10 µM; Vybrant Cell Tracer kit; Life 
Technologies) for 10 min at 37°C and washed thoroughly 
immediately prior to cotransplantation.
TNF-a Treatment of EPCs
EPCs were treated with TNF-a (5 ng/ml) for 5 h. 
Cells were harvested with 0.1% trypsin–EDTA (2–3 min 
at 37°C) and stained with primary antibodies for 30 min 
at 4°C. Cells were stained with secondary antibodies 
(30 min at 4°C) and analyzed with the flow cytometer 
(Beckman Coulter XL-MCL; Gladesville, Australia).
Murine Islet Isolation and Culture
All experimental procedures were approved by the 
Animal Ethics Committee of the University of Adelaide and 
conform to the guidelines established by the Australian Code 
of Practice for the Care and Use of Animals for Scientific 
Purposes. Pancreatic islets were isolated from 6- to 12-week-
old male C57B6 mice (University of Adelaide Laboratory 
Animal Services, SA, Australia). Briefly, 3 ml cold M199 
medium (Sigma) containing 0.67 mg collagenase (Liberase 
TL grade; Roche) per pancreas was infused into the pancre-
atic duct in situ. The pancreas was removed and digested 
at 37°C for 14–16 min. Islets were purified on a discon-
tinuous Ficoll gradient (GE Healthcare, Buckinghamshire, 
UK). Following extensive washing, islets were cultured 
free floating (37°C, 5% CO2) in Roswell Park Memorial 
Institute medium (RPMI; Sigma) supplemented with l-glu-
tamine, penicillin, streptomycin, and 10% fetal calf serum 
(RPMI–FCS) for up to 4 days. For coculture experiments, 
25 islets per well were handpicked to be plated on nonper-
meable Transwell inserts (0.4-µm pores; Corning, Clayton, 
Australia) above EPC monolayers seeded onto fibronectin-
coated wells. For contact coculture experiments, islets (50 
per well) were added to EPC monolayers and cultured for 
4 h prior to RNA extraction (RNAeasy Mini Kit; Qiagen, 
Hilden, Germany).
Detection of Intraislet Endothelial Cells
Handpicked islets were dissociated with Accutase 
(37°C, 5 min; Sigma), strained through a tube-top strainer 
[BD Bioscience (BD Falcon), San Jose, CA, USA] and 
recovered in RPMI–FCS for 30 min at 4°C. Following 
blocking, cells were stained with directly conjugated 
antibodies for 30 min at 4°C and analyzed at the flow 
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cytometer (Beckman Coulter XL-MCL; Gladesville, 
Australia) and using FCS express software (version 3.0, 
De Novo Software, Los Angeles, CA, USA).
Quantitative Real-Time PCR
Grafted kidneys were homogenized into RLT buffer 
using a TissueLyserII (Qiagen). RNA was isolated from 
kidney homogenates or purified islets using QIAshredder 
columns and an RNAeasy Mini Kit (Qiagen) and treated 
to remove genomic DNA (TURBO DNA-free kit; 
Ambion, Life Technologies), prior to reverse transcription 
(Omniscript; Qiagen). Real-time quantitative PCR analysis 
was performed on triplicate samples using the following 
gene-specific Taqman® primers (Applied Biosystems; Life 
Technologies): insulin 1 (INS; Mm01259683_g1), con-
nexin 36 (Cx36, Mm00439121_m1), connexin 43 (Cx43; 
Mm00439105_m1), connexin 45 (Cx45; Mn01253027_
m1), E-cadherin (Ecad) (Cdh1; Mm01247357_m1), vascular 
endothelial growth factor A (VEGFA; Mm01281449_m1), 
hepatocyte growth factor (HGF; Mm01135193), collagen 
type 1 a 1 (Col1A1; Mm00801666_g1), integrin b1 (ITGB1; 
Mm01253230_m1), and fibronectin (Fn1; Mm01256744_
m1). b-2-microglobulin (B2M; Mm00437762_m1) was 
used as a housekeeping gene to normalize expression 
data, and hypoxanthine-guanine phosphoribosyltransferase 
(HPRT; Mm00446968_m1) was used as a confirmatory 
housekeeper. Mean normalized expression values were 
calculated using Qgene Module software (Kansas State 
University, Manhattan, KS, USA; http://www.qgene.org/
qgene/index.php) as previously described (27).
Immunohistochemistry
The graft-bearing kidney was harvested, fixed in buff-
ered formalin (10% buffered formalin, ACE Chemical 
Company, Camden Park, Australia), and processed 
into paraffin blocks. Serial sections (5 µm) were taken 
through the graft, and every 10th section was processed 
for hematoxylin–eosin (Sigma-Aldrich) staining to iden-
tify the graft site. Sections were dewaxed in xylene and 
rehydrated prior to antigen retrieval with Proteinase K 
(Roche Australia, Dee Why, Australia) at 37°C for 20 min. 
Sections were blocked with 10% normal donkey serum 
(Sigma-Aldrich) and processed for immunofluorescence 
detection of insulin and fluorescein (fluorescein-labeled 
tomato lectin). Digital images were obtained using an 
Olympus BX50 fluorescence microscope (Macquarie 
Park, NSW, Australia) with LED illumination. Images 
were prepared using ImageJ software (NIH, Bethesda, 
MD, USA; http://rsb.info.nih.gov/ij).
Intraperitoneal Glucose Tolerance Test
Mice were fasted for 18 h and given 2 g/kg glucose 
[d-(+)-glucose solution (10%); Sigma Aldrich] by intrap-
eritoneal (IP) injection. Tail vein blood samples were taken 
prior to injection and at 15, 30, 60, and 120 min postinjec-
tion. Whole blood was analyzed for glucose using a glu-
cometer (Optium, Abbott Diabetes Care, Victoria, Australia) 
and using the low range of a high-sensitivity murine insulin 
ELISA kit (Crystal Chem, Inc., Downers Grove, IL, USA).
Islet Transplantation Under the Kidney Capsule
C57B6 mice were rendered diabetic by IP injection of 
180–200 mg/kg streptozotocin (Sigma-Aldrich) in cit-
rate buffer (BDH Chemicals, Kilsyth, VIC, Australia). 
Diabetes was confirmed by two consecutive blood glu-
cose readings higher than 16.6 mM (39). Diabetic mice 
were transplanted with a minimal mass (200 islets) of 
cultured islets under the kidney capsule with or without 
day 7 EPCs (1 × 106 cells). Cure of diabetes was defined as 
the first day of two consecutive nonfasted blood glucose 
readings of <11.1 mM with no subsequent reversion to 
hyperglycemia (two consecutive readings above 11.1 mM).
Glucose-Stimulated Insulin Release
Islets were handpicked into basal Krebs buffer (3 mM 
glucose; BDH Chemicals) at 37°C (basal). Groups of 
10 islets were transferred into fresh basal Krebs buffer 
(3 mM glucose) at 37°C for 1 h. In some experiments, 
the Cx36 inhibitor mefloquine (10 µM) was included 
throughout the culture periods. Islets were spun briefly 
and supernatant replaced with Krebs buffer with high 
glucose (20 mM) at 37°C for 10 min (first phase). Islets 
were spun briefly, and the supernatant was replaced with 
Krebs buffer with high glucose (20 mM) at 37°C for 
50 min (second phase). Following recovery in basal buf-
fer for 1 h, islets were incubated with high potassium 
Krebs buffer (70 mM; High K+; BDH Chemicals) at 37°C 
for 30 min. Islets were spun, and supernatant was col-
lected. Total pellet proteins were extracted by resuspend-
ing islets in RIPA buffer [0.1% sodium dodecyl sulfate 
(SDS); 100 mM phenylmethansulfanyl fluoride serine 
protease inhibitor; BDH Chemicals] and subjecting to 10 
freeze–thaw cycles in liquid nitrogen. Protein concentra-
tion was estimated using the EZYQ Protein Estimation 
Assay (Life Technologies) as per the manufacturer’s 
instructions. Supernatants were analyzed for insulin con-
centration using the Ultra Sensitive Mouse Insulin ELISA 
Kit (low-range assay; Crystal Chem, Inc.). Stimulation 
indices were calculated by dividing insulin secretion val-
ues at basal glucose levels by those detected in the first 
phase of high glucose.
Statistics
Endothelial cell enumeration data over time was 
compared by one-way ANOVA with Bonferroni post-
test. Cure rates were compared between groups by log-
rank (Mantel–Cox) test. Blood glucose levels within the 
revascularization period (days 3–14 posttransplant) were 
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analyzed using area-under-the-curve (AUC) analysis of 
log10 transformed data, and AUC values were compared by 
one-tailed unpaired t tests. Mean normalized gene expres-
sion data were compared by unpaired t tests. Analyses 
were performed using Prism 5 for Windows (Version 
5.04; Graphpad, San Diego, CA, USA) software.
RESULTS
Intraislet Endothelial Cells Are Rapidly Lost in Culture
To investigate the persistence of endothelial cells in 
murine pancreatic islets during culture, endothelial cells 
were enumerated in isolated islets by flow cytometry 
(Fig. 1). At various timepoints, handpicked islets were dis-
persed into single-cell suspensions, stained for the endothe-
lial cell marker CD31, and analyzed by flow cytometry 
(Fig. 1A). In freshly isolated islets, CD31+ endothelial 
cells comprised 2.5 ± 0.1% of total islet cells. After 1 day 
of culture, 73 ± 20% of the endothelial cells persisted, and 
following 4 days of culture, this was significantly reduced 
to 12 ± 3% of the original number ( p < 0.005) (Fig. 1B). 
These data indicate that following islet isolation, CD31+ 
intraislet endothelial cells are rapidly lost from the islet 
structure during culture.
Cotransplanted Endothelial Progenitor Cells Speed 
the Engraftment of Transplanted Pancreatic Islets
To examine whether EPCs could enhance the engraft-
ment of pancreatic islets, EPCs were cotransplanted under 
the kidney capsule of diabetic mice with a marginal mass 
of islets. Since we were interested in whether EPCs can 
replenish the endothelial cells that are lost during culture 
(Fig. 1), we used islets that had been cultured in vitro for 
3 days prior to transplantation. To obtain EPCs, bone mar-
row cells were cultured with a commercial endothelial 
cell growth supplement (containing VEGF and fibroblast 
growth factor) on fibronectin-coated plates to promote 
the vascular endothelial lineage. Our extensive character-
ization of these cells has been previously published (4). 
Briefly, these EPCs were shown to express CD144 at their 
cell surface and were positive for CD34, c-kit, stem cell 
antigen-1 (sca-1), fetal liver kinase 1 (Flk-1; VEGFR2), 
CD133, CD146, CD31, endothelial nitric oxide synthase 
(eNOS), von Willebrand factor (vWF), Tunica interna 
endothelial cell kinase (Tie2; angiopoietin-1 receptor), 
chemokine C-X-C motif receptor 2 (CXCR2), CXCR4, 
a5-integrin, b1-integrin, CD45, and CD11b surface anti-
gen, CD14 low and negative for CD105, and CD90 
message (4). Moreover, they form capillary-like tubes 
in vitro using the three-dimensional Matrigel assay (4). 
Herein, we further validate their endothelial lineage 
(Fig. 2) by showing that they efficiently bound fluorescein- 
labeled tomato lectin (which selectively binds rodent vas-
cular endothelium; Fig. 2A) and upregulated E-selectin 
upon TNF-a treatment (Fig. 2B). In initial transplantation 
experiments, the marginal dose of day 3 cultured islets 
required to cure approximately half of recipients was 
determined as 200 islets. To examine the effect of EPC 
cotransplants, mice received this marginal mass of islets, 
with or without EPCs, under the kidney capsule and were 
monitored daily for nonfasted blood glucose and body 
weight. There was a significantly improved cure rate in 
cotransplanted animals compared to controls ( p = 0.002) 
(Fig. 3). Revascularization in the mouse occurs within 
14 days posttransplantation (21). Thus, following the 
expected revascularization period, the percentage cure 
in cotransplanted animals at day 14 was 83%, compared 
to 20% in the islets-only control group. There was sig-
nificantly improved posttransplant weight gain in the 
mice receiving cotransplanted EPCs compared to mice 
receiving islets alone (data not shown; p = 0.007). Blood 
Figure 1. Intraislet endothelial cell density decreases rapidly during islet culture. Isolated islets (25–60 islets per well) were dispersed 
and endothelial cells enumerated at different timepoints during culture by flow cytometric detection of cluster of differentiation 31 
(CD31). (A) Representative flow cytometry dot plot. Dotted line represents gating region for CD31–PE+ cells within dispersed islets. 
(B) Endothelial cell density is expressed as mean ± SEM relative to the values at day 0. *p < 0.05 compared to day 4; **p < 0.005 
 compared to day 0; n = 4 mice. PE, phycoerythrin; FSC-A, forward scatter.
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glucose levels during the revascularization period (days 
3–14) in cotransplanted animals were significantly lower 
compared to the islets-alone group ( p = 0.002) (Fig. 3D). 
To examine the ultimate in vivo function of transplanted 
islets among the groups, only cured animals were chal-
lenged with a bolus of IP glucose 28 days after transplan-
tation (Fig. 3E). Owing to the small numbers of cured 
animals in the islets-only group, differences were not 
significant. Diabetic mice receiving EPCs only or sham 
operations did not experience improved glycemic con-
trol following transplant (Fig. 4), suggesting that EPCs 
act to enhance the function of transplanted islets rather 
than causing the regeneration of endogenous islets. Thus, 
cotransplantation of EPCs improved the cure rate and 
glycemic control of a marginal mass of syngeneic islets 
into STZ-treated diabetic mice.To examine the in vivo 
fate of cotransplanted EPCs, CFDA-labeled EPCs were 
cotransplanted with islets, and tissues were harvested at 
various timepoints posttransplant. EPCs were detected 
under the kidney capsule at day 7 in close proximity to 
the graft (Fig. 3F) but were undetectable at day 28. EPCs 
were absent from the circulation, the draining renal 
lymph node, and distant (facial) lymph node at all points 
posttransplantation (Fig. 5). These results suggest that 
cotransplanted EPCs mediate the improvement of islet 
transplantation locally at the graft site in the early post-
transplantation period.
EPC-Derived Factors Regulate Islet Function and 
b-Cell Connexin Expression In Vitro
We investigated whether soluble EPC-derived fac-
tors modify islets in vitro (Fig. 6). Islets were cul-
tured in EPC-conditioned medium for 3 days, and their 
 glucose-stimulated insulin release response was mea-
sured. During culture, freshly harvested medium was 
delivered to the islets daily to ensure that consumed fac-
tors were replenished. By examining the absolute amount 
of insulin released in each phase of glucose stimulation 
(relative to total protein; Fig. 6A), it was apparent that 
EPC-conditioned islets had an increased level of basal 
insulin release ( p < 0.05), which partially explains the 
decreased stimulation index found in EPC-conditioned 
islets ( p < 0.01) (Fig. 6B). There were no significant dif-
ferences in the amount of insulin secreted during either 
the first or second phase response to high glucose. High 
potassium, which elicits the release of remaining stored 
insulin granules, resulted in similar levels of insulin being 
released, suggesting there was no difference in insulin 
protein translation or processing. The data suggest that 
EPC-conditioned islets have altered insulin release kinet-
ics, rather than differences in insulin protein production 
or packaging. To investigate the mechanisms underlying 
the EPC-associated increase in basal insulin release, a 
separated Transwell coculture experiment was performed, 
where islets were grown in the presence of, but not in 
physical contact with, EPCs for 3 days (Fig. 6C). During 
culture, islet phenotype appeared altered, with many of 
the cocultured islets exhibiting a more adherent/stretched 
appearance compared to islets cultured alone (Fig. 6D). 
To examine underlying gene expression changes, islets 
were processed for real-time PCR analyzing a number 
of genes known to play a role in intraislet cell signaling 
(Fig. 6E). Ecad and Cx36 are two b-cell surface molecules 
suggested to be important for cell–cell tethering in coor-
dinated islet insulin release (7,17). VEGF-A is secreted 
by b-cells and is likely to play a role in communication 
with islet vasculature (43). The integrin b1 chain (ITGB1) 
and its interaction with extracellular matrix components, 
such as type 1 collagens (Col1A1) and fibronectin (Fn1), 
are important for islet b-cell function (12,34). There was 
Figure 2. Bone marrow-derived murine EPCs bind lectin and upregulate E-selectin. (A) Cultured bone marrow-derived EPCs were 
analyzed for lectin binding by flow cytometry. Unstained cells (dashed line) and fluorescein isothiocyanate-labeled lectin stained cells 
(filled histogram) are shown. (B) Upregulation of E-selectin was examined in EPCs cultured in the presence of tumor necrosis factor-a 
(TNF-a; 5 ng/ml) for 5 h with a representative of five experiments shown. Nontreated controls (dotted line) and TNF-treated cells 
(black histogram) were stained with anti-E-selectin. Isotype control on treated cells is shown (gray histogram).
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no significant difference in the transcript levels of insu-
lin, Ecad, VEGF, collagen, integrin-1b, or fibronectin. 
Cx36 expression was significantly decreased in cocul-
tured islets compared to islets cultured alone (p < 0.04; 
0.4 ± 0.05-fold). Interestingly, pharmacological blockade 
of Cx36 with the inhibitor mefloquine in normal mouse 
islets caused a similar perturbation in glucose-stimulated 
insulin secretion (data not shown) as to that observed in 
islets cultured with EPC-conditioned medium (Fig. 6B). 
These data indicate that soluble factors produced by 
Figure 3. EPC cotransplantation improves cure rate of islet transplantation in a marginal mass model. Posttransplantation (day 
post-Tx) daily nonfasted blood glucose levels (BGL) of diabetic mice that received 200 islets (A) or 200 islets with 106 EPCs (B) under 
the kidney capsule. Each line represents one recipient mouse. #Animals humanely killed due to poor health or weight loss. Dotted 
line represents euglycemia (BGL < 11.1 mM). (C) Survival curve analysis shows improved rate of diabetes cure in animals receiving 
islets with EPCs (white squares; n = 12) compared to islets only (filled triangles; n = 10) (p = 0.002). (D) Average BGL (mean ± SEM) 
in groups that received islets only (filled triangles; n = 10) or islets with EPCs (white squares; n = 12). Euglycemic levels (BGL < 11.1 
mM; shaded area) are shown. (E) Cured mice from each group were challenged at 28 days after transplant with 2 g/kg bodyweight 
of glucose injected intraperitoneally. Blood glucose levels were measured at various timepoints postinjection. Mean BGL ± SEM are 
shown for groups bearing islet-only grafts (dashed line/triangle; n = 2) or cotransplanted islets and EPCs (black line/square; n = 11). 
Cage-mate controls (dotted line/circle; n = 6) are shown for comparison. (F) Detection of CFDA-labeled EPCs (green) under the kidney 
capsule of mice cotransplanted with islets and EPCs 7 days earlier. The engrafted islet mass is shown stained for insulin (red). Scale 
bar: 100 µm.
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EPCs in culture are able to modulate the expression of 
the b-cell surface molecule Cx36, which may result in 
the dysregulation of glucose-stimulated insulin release in 
vitro.
EPCs Modulate b-Cell Connexin 36 Expression via 
Soluble and Cell Contact Mechanisms
In order to examine whether Cx36 expression levels 
were also modulated by cell contact, EPCs and islets were 
cultured together for 4 h and processed for real-time PCR 
(Fig. 7). EPC doubling time ranges between 24 and 40 h 
(28), and the short coculture period was used to avoid the 
confounding influence of cell division and/or cell death. 
The coculture mixture was harvested and analyzed for gene 
expression. Gene levels are shown relative to the matched 
control: EPC-only and islet-only monocultures (matched 
for cell number) that were combined at the RNA extrac-
tion step. Genes examined included the b-cell-derived 
genes insulin, VEGF, and Cx36. While Cx36 expression 
is restricted to b-cells, intraislet endothelial cells express 
Cx43 and Cx45 (40). EPCs are known to express multiple 
angiogenic factors, including hepatocyte growth factor, 
which has particular relevance for b-cell survival (26). 
Thus, the expression of Cx43 and Cx45 and hepatocyte 
growth factor was measured in the cocultured samples. 
Again, Cx36 expression was significantly decreased during 
EPC contact coculture ( p < 0.05; 0.3 ± 0.10-fold compared 
to controls) (Fig. 7B). Insulin expression was also reduced 
( p < 0.04; 0.6 ± 0.07-fold compared to postmix controls), 
suggesting that cellular contact between islet cells and 
EPCs may modify insulin expression at the mRNA level. 
Some grafted kidneys were analyzed for Cx36 mRNA 
expression at day 6–28 posttransplant, but there was no dif-
ference between kidneys bearing islets only compared to 
islets with EPC cotransplants (data not shown). Together, 
these data confirm that in vitro EPCs have the ability to 
modulate the expression of b-cell gap junction proteins 
including Cx36 and that this may occur rapidly when cells 
are in direct contact. Whether Cx36 is relevant for the in 
vivo function of islets in the context of transplantation will 
be an area of further study.
DISCUSSION
Intraislet endothelial cells have an increasingly appre-
ciated role in supporting b-cell gene transcription, insulin 
secretion, survival, and proliferation. Here we have shown 
that intraislet endothelial cells are lost rapidly during islet 
culture and that exogenously delivered EPCs improve the 
cure rate of a marginal transplanted islet mass in a syn-
geneic diabetic mouse model. While potentially enhanc-
ing the engraftment and revascularization of transplanted 
islets in the early posttransplant period, these studies indi-
cate that EPCs (or the soluble factors they produce) also 
directly impact b-cells, modulating the expression of the 
important b-cell molecule, Cx36.
Intraislet endothelial cells decreased rapidly dur-
ing culture following islet isolation. These findings are 
unlikely to be due to dedifferentiation, or reduction in 
CD31 expression, because studies utilizing a GFP lineage-
tagging technique have reported similar results (29). In 
the transplant setting, this decrease is likely to be impor-
tant as donor islet-derived endothelial cells contribute to 
the formation of critical new blood vessels posttransplan-
tation (5), along with the ingrowth of recipient-derived 
endothelial cells and bone marrow-derived cells (11,29). 
The consequent paucity of endothelial cells in cultured 
islets may in part explain their inferior graft survival 
compared to fresh islets (23,31). Surprisingly, a recent 
study examining islet engraftment into the anterior cham-
ber of the eye found that fresh islets (containing relatively 
more endothelial cells) took longer to revert diabetes than 
4-day cultured islets (30). However, compared to the 
kidney and the liver, the eye has a high oxygen tension, 
which may decrease the relative importance of revascu-
larization responses for islet function at this site. Thus, 
the density of intraislet endothelial cells, and how quickly 
Figure 4. EPCs alone do not improve glycemic control in dia-
betic mice. Posttransplantation (day post-Tx) daily nonfasted 
blood glucose levels (BGL) of diabetic mice that received 
106 EPCs alone (A; n = 5) or phosphate-buffered saline (PBS) 
(B; sham, n = 2) under the kidney capsule. Each line repre-
sents one recipient mouse. Dotted line represents euglycemia 
(BGL < 11.1 mM).
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Figure 5. Tracking of transplanted EPCs in vivo. EPCs were not detected in the circulation following cotransplantation under the kid-
ney capsule. Pretransplantation labeled EPCs were gated by forward/side scatter (FSC/SSC) (A) and examined for green  fluorescence 
[carboxyfluorescein diacetate succinimidyl ester (CFDA)] at the flow cytometer. (B) Labeled EPCs (filled histogram) showed a high 
level of fluorescence postlabeling compared to unlabeled cells (unfilled histogram). (C) Detection of 100 CFDA-labeled cells spiked 
into a full mouse blood preparation. (D) Mice cotransplanted with islets and labeled EPCs under the kidney capsule did not have 
detectable levels of labeled cells in their draining renal lymph nodes, ipsilateral facial lymph nodes, or blood at days 1, 7, or 28 
posttransplantation.
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intraislet vascular connections become reestablished after 
transplantation, is likely to impact the function of pancre-
atic islets.
Possible mechanisms through which EPCs may sup-
port b-cell function and survival include via the produc-
tion of soluble factors and through the direct interaction 
of cell surface molecules. We found that the culture of 
islets with EPC-conditioned media increased the amount 
of insulin released at basal glucose levels, but not at high 
glucose levels (Fig. 6). Thus, this change may represent 
a dysregulation of insulin release rather than an overall 
increase. These data conflict somewhat with those of 
Johansson et al. (21) who demonstrated that endothe-
lial cell-derived soluble factors moderately enhance 
glucose-stimulated insulin release from rat islets in vitro. 
However, their study examined mature endothelial cells, 
and they postulated that endothelium-derived laminins 
were behind this improvement. It may be that mature 
endothelial cells produce more laminin than the immature 
EPCs tested here.
Other researchers have described an upregulation 
of islet-derived VEGF-A mRNA when cocultured with 
EPCs (22). There are two main differences between our 
experiments. Firstly, we utilized a syngeneic coculture 
system, deriving both EPCs and islets from mice, whereas 
Kang et al. examined the coculture of human umbilical 
cord blood-derived EPCs and murine islets. Second, our 
long-term culture experiments (3 days) were in physically 
separated cocultures, compared to using EPCs to coat the 
islets in culture. Thus, the robust upregulation of VEGF-A 
mRNA in response to EPCs described by Kang et al. (22) 
may be cell contact dependent.
We observed that extended culture with EPC-derived 
humoral factors, or short-term cell contact with EPCs, 
decreased the expression of Cx36 and increased basal 
insulin release in islets in vitro. Connexins are one group of 
molecules likely to be important for cell contact-mediated 
effects between b-cells and endothelial cells. Hexamers 
of these molecules form halves of gap junctions, with the 
ability to form complete channels with either connexins 
of the same (homojunctions) or different type (hetero-
junctions). Though Cx36 expression was initially thought 
to be restricted to neurons (10), it is the major connexin in 
pancreatic b-cells (37). Cx36 gap junctions allow the pas-
sage of ions and small molecules [in particular, Ca2+ and 
cyclic adenosine monophosphate (cAMP) (9)] between 
the cytoplasms of b-cells during synchronized glucose-
induced Ca2+ oscillations (3,34). A particularly important 
function of Cx36 in islets is to extinguish Ca2+ elevations 
following membrane depolarizations (3,36,39). Thus, Cx36 
connections within the islet allow less excitable b-cells 
to act as a buffer, suppressing electrical activity in their 
neighbors. Cx43 and Cx45 have been recently localized 
to endothelial cells within pancreatic islets (8,37,40), 
and it is tempting to entertain the possibility that b-cells 
and endothelial cells may communicate directly, via the 
exchange of electrical messages through heterotypic con-
nexin junctions. Whether such connections are important 
in pancreatic islets remains to be established.
Herein we demonstrate that cotransplantation of EPCs 
with pancreatic islets improved the cure rate of a marginal 
mass of islets in a syngeneic murine transplant model. 
Despite having improved glucose control in the early 
transplant period, the ultimate function of transplanted 
islets in cured animals after 1 month was not signifi-
cantly better than controls. Similarly, Nyqvist and col-
leagues (30) demonstrated moderately increased vascular 
Figure 7. EPC contact modulates gene expression in islets in 
vitro. (A) Diagrammatic representation of islet/EPC contact 
coculture system. Islets (50 per well) were added to EPC mono-
layers and cultured for 4 h prior to RNA extraction. Control 
cultures comprised cell number matched monocultures (islet 
only or EPCs only) that were combined prior to RNA extraction 
step. (B) Gene expression levels of b-cell-derived or endothelial 
genes were analyzed by quantitative RT-PCR. Bars represent 
average fold change (±SEM) of mean gene expression values 
(normalized to B2M) in islet/EPC cocultures (black bars) rela-
tive to controls (white bars; monocultures combined at RNA 
extraction step). *p = 0.05 and **p = 0.04 compared to control 
cultures. HGF, hepatocyte growth factor.
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density early posttransplantation when using fresh islets 
compared to cultured islets, but no difference at 1 month 
despite the long-term persistence of donor endothelial 
cells. Recent work from another group has shown that 
human EPC cotransplants speed the revascularization of 
porcine islets in diabetic nude mice (22). Importantly, 
the final engrafted b-cell mass was significantly better in 
cotransplanted mice, even though there was no difference 
in capillary density at 1 month posttransplantation. Thus, 
the main advantage of EPC cotransplantation may be to 
hasten the revascularization response posttransplantation. 
Whether this results in significantly improved graft func-
tion in the longer term may depend on the model used. 
Considering the large amount of cell death seen in clini-
cally transplanted islets in the early posttransplant period, 
any enhancement of revascularization may translate to 
clinical improvement in transplantation outcomes.
In conclusion, the provision of EPCs during transplan-
tation has the potential as a cell-based cotransplantation 
therapy to improve the engraftment of pancreatic islets. 
Within islets, it is likely that b/endothelial crosstalk is medi-
ated via both humoral and cell contact- dependent mecha-
nisms. While further mechanistic research is required, cell 
surface molecules involved in intraislet communication 
(such as Cx36) may represent important clinical targets in 
the future.
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